Malpass Urges Advanced Nations to Free Up Excess Vaccines

The transcript discusses the potential links between vaccines and blood clots, and the impact on emerging market recovery. It highlights the World Bank's efforts in distributing vaccines to developing countries, emphasizing the need for growth and vaccination readiness. The conversation also addresses the challenges of vaccine supply, with $12 billion available but only $4 billion spent due to supply restrictions. Solutions include engaging manufacturers and encouraging advanced economies to share excess supply.

What is a major concern regarding the vaccine's impact on emerging markets?

• The vaccine's effectiveness in cold climates

• Possible links between the vaccine and blood clots

• The cost of the vaccine for developed countries

• The vaccine's storage requirements

What is the World Bank's strategy to support vaccination in poorer countries?

• Providing free vaccines to all countries

• Funding vaccination programs and assessing readiness

• Building new vaccine manufacturing plants

• Training new vaccinators in developed countries

What is a significant challenge faced by the World Bank in vaccine distribution?

• Lack of funding

• Insufficient supply from advanced economies

• High transportation costs

• Vaccine storage issues

What is a critical step needed to improve vaccine distribution to poorer countries?

• Developing new vaccine formulas

• Reducing vaccine doses

• Advanced economies sharing excess supply

• Increasing vaccine prices

What is being urged to advanced economies regarding vaccine contracts?

• To increase the price of vaccines

• To prioritize their own populations

• To delay their vaccine contracts

• To share information and release excess supply